Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China
• First glucokinase-activator (GKA) approval outside mainland China • Approval supports a differentiated approach to T ype 2 diabetes (T2D) management • Hong Kong will...